GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gujarat Inject (Kerala) Ltd (BOM:524238) » Definitions » YoY EBITDA Growth

Gujarat Inject (Kerala) (BOM:524238) YoY EBITDA Growth : 65.85% (As of Mar. 2025)


View and export this data going back to 2003. Start your Free Trial

What is Gujarat Inject (Kerala) YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Gujarat Inject (Kerala)'s YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 65.85%.

Gujarat Inject (Kerala)'s EBITDA per Share for the three months ended in Mar. 2025 was ₹0.07.


Gujarat Inject (Kerala) YoY EBITDA Growth Historical Data

The historical data trend for Gujarat Inject (Kerala)'s YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gujarat Inject (Kerala) YoY EBITDA Growth Chart

Gujarat Inject (Kerala) Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 102.79 1,783.33 -21.24 870.79

Gujarat Inject (Kerala) Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 141.18 33.33 1,125.00 1,330.77 65.85

Gujarat Inject (Kerala) YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Gujarat Inject (Kerala)'s YoY EBITDA Growth for the fiscal year that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (A: Mar. 2025 )
=(EBITDA per Share (A: Mar. 2025 )-EBITDA per Share (A: Mar. 2024 ))/ | EBITDA per Share (A: Mar. 2024 ) |
=(0.864-0.089)/ | 0.089 |
=870.79 %

Gujarat Inject (Kerala)'s YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (Q: Mar. 2025 )
=(EBITDA per Share (Q: Mar. 2025 )-EBITDA per Share (Q: Mar. 2024 )) / | EBITDA per Share (Q: Mar. 2024 )) |
=(0.068-0.041)/ | 0.041 |
=65.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gujarat Inject (Kerala) YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Gujarat Inject (Kerala)'s YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Gujarat Inject (Kerala) Business Description

Traded in Other Exchanges
N/A
Address
SB-06, Paradise Complex, Opposite M.S. University, Sayajiganj, Vadodara, GJ, IND, 390 005
Gujarat Inject (Kerala) Ltd is engaged in the trading of intravenous fluids.

Gujarat Inject (Kerala) Headlines

No Headlines